A randomised controlled trial of Huoxue Jiedu therapy in the treatment of unstable angina based on Yu and Du etiology theory

A systematic study of the Yu and Du etiology theory of cerebral cardiovascular thrombotic diseases

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-07000023

Enrollment

Unknown

Registered

2007-10-31

Start date

2008-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable angina

Interventions

Huoxue group:Conventional therapy + Gongshao capsule

Huoxue Jiedu group:Conventional therapy + Gongshao capsule+Huanglian capsule

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. diagnosed as unstable angina; onset within 24 hours; 2. To be aged between 40 and 75 years; 3. signing informed consent.

Exclusion criteria

Exclusion criteria: 1. history of infection, fever, trauma, or surgery within the recent month; 2. presence of acute myocardium infarction, or acute cerebral accident within the recent month; 3. active autoimmune diseases; 4. active tuberculosis; 5. malignancy; 6. patients with liver cirrhosis, renal failure, or organ transplantation.

Design outcomes

Primary

Measure	Time frame
Cardiovascular events rate;	—

Secondary

Measure	Time frame
Tissue response;	—

Countries

China

Contacts

Public ContactKeji Chen, Dazhuo Shi

heartmail@263.net+86 010 62860499

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026